Status:
COMPLETED
Assessment of the Effectiveness of Chemotherapy Teaching: BrUOG 258
Lead Sponsor:
Brown University
Collaborating Sponsors:
Rhode Island Hospital
The Miriam Hospital
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study will evaluate whether chemotherapy teaching sessions improves patient's knowledge, preparedness and anxiety in relation to chemotherapy. This study will also evaluate the effect of age, rac...
Detailed Description
Chemotherapy teaching sessions, often coordinated in the outpatient setting by nursing personnel, are meant to educate patients about the chemotherapy they will be receiving. Education topics include ...
Eligibility Criteria
Inclusion
- Patients \> 18 years of age who will be receiving chemotherapy (including targeted anticancer therapy) at a Brown University Oncology Research Group Affiliated Hospital for a period of 1-year after study activation.
- Patients who will be undergoing a chemotherapy teaching session at an institution affiliated with the Brown University Oncology Research Group.
- No prior chemotherapy or targeted anticancer treatment.
- Signed informed consent
Exclusion
- Patients must meet eligibility criteria
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT01827761
Start Date
October 1 2011
End Date
May 1 2014
Last Update
February 24 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Hospital
Pawtucket, Rhode Island, United States, 02860
2
Rhode Island Hospital (including Newport)
Providence, Rhode Island, United States, 02903
3
The Miriam Hospital
Providence, Rhode Island, United States, 02906
4
Roger Williams Medical Center
Providence, Rhode Island, United States, 02908